Genetic assay for multimerization of retroviral gag polyproteins

We have established a genetic assay for the multimerization of retroviral gag polyproteins. This assay is based on the GAL4 two-hybrid system for studying protein-protein interactions (S. Fields and O. Song, Nature (London) 340:245-246, 1989). In our initial experiments, we generated Saccharomyces cerevisiae plasmids that separately express the GAL4 DNA-binding and GAL4 activation domains fused to the human immunodeficiency virus type 1 (HIV-1) gag polyprotein, Pr55gag. The coexpression of these two hybrid proteins in S. cerevisiae results in the association of the GAL4 domains and the potent activation of an integrated GAL4-responsive lacZ indicator gene. Similar results were obtained with plasmids encoding GAL4-Moloney murine leukemia virus (M-MuLV) gag polyprotein hybrid proteins. In contrast, the heterologous GAL4-HIV-1 gag and GAL4-M-MuLV gag fusion proteins were unable to interact with each other to induce lacZ expression. The results suggest that this yeast system provides a rapid and specific assay for the interactions of retroviral gag proteins that occur during virion assembly.

[1]  D. Shore,et al.  A RAP1-interacting protein involved in transcriptional silencing and telomere length regulation. , 1992, Genes & development.

[2]  S. Fields,et al.  The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R C Craven,et al.  Form, function, and use of retroviral gag proteins. , 1991, AIDS.

[4]  J. Luban,et al.  Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein , 1991, Journal of virology.

[5]  H. Gelderblom.  Assembly and morphology of HIV: potential effect of structure on viral function. , 1991, AIDS.

[6]  D. Littman,et al.  Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity , 1990, Journal of virology.

[7]  E. Wimmer,et al.  Expression in Escherichia coli and purification of human immunodeficiency virus type 1 capsid protein (p24). , 1990, AIDS research and human retroviruses.

[8]  D. Baltimore,et al.  HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus , 1989, Cell.

[9]  E. Jacobs,et al.  Assembly and release of HIV-1 precursor Pr55 gag virus-like particles from recombinant baculovirus-infected insect cells , 1989, Cell.

[10]  J. Sodroski,et al.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[12]  S. Goff,et al.  Sequence and spacing requirements of a retrovirus integration site. , 1988, Journal of molecular biology.

[13]  Mark Ptashne,et al.  Mutants of GAL4 protein altered in an activation function , 1987, Cell.

[14]  M. Shibuya,et al.  Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. , 1985, Virology.

[15]  S. Goff,et al.  A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins , 1985, Journal of virology.

[16]  L. Breeden,et al.  Regulation of the yeast HO gene. , 1985, Cold Spring Harbor symposia on quantitative biology.

[17]  S. Goff,et al.  Construction and analysis of deletion mutations in the pol gene of moloney murine leukemia virus: A new viral function required for productive infection , 1984, Cell.

[18]  S. Goff,et al.  Mutations in the gag gene of Moloney murine leukemia virus: effects on production of virions and reverse transcriptase , 1984, Journal of virology.

[19]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[20]  P. Jolicoeur,et al.  Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses , 1983, Journal of virology.

[21]  R. Pepinsky.  Localization of lipid-protein and protein-protein interactions within the murine retrovirus gag precursor by a novel peptide-mapping technique. , 1983, The Journal of biological chemistry.

[22]  M. Hayman,et al.  Analysis of cells transformed by defective leukemia virus OK10: production of noninfectious particles and synthesis of Pr76gag and an additional 200,000-dalton protein. , 1980, Virology.

[23]  R. Eisenman,et al.  Synthesis and processing of polymerase proteins of wild-type and mutant avian retroviruses , 1980, Journal of virology.

[24]  W. N. Burnette,et al.  Synthesis and processing of viral glycoproteins in two nonconditional mutants of Rous sarcoma virus , 1980, Journal of virology.

[25]  V. Vogt,et al.  Chemical crosslinking of proteins in avian sarcoma and leukemia viruses. , 1980, Virology.

[26]  W. S. Hayward,et al.  An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: Biological and biochemical characterization , 1978, Cell.

[27]  D. Baltimore,et al.  High frequency of aberrant expression of moloney murine leukemia virus in clonal infections , 1978, Cell.

[28]  W. N. Burnette,et al.  Physical and chemical properties of Moloney murine leukemia virus p30 protein: a major core structural component exhibiting high helicity and self-association. , 1976, Journal of molecular biology.

[29]  I. K. Berezesky,et al.  Deficiency of 60 to 70S RNA in Murine Leukemia Virus Particles Assembled in Cells Treated with Actinomycin D , 1974, Journal of virology.